What we're reading, January 19, 2017: California has withdrawn a request to sell health coverage for illegal immigrants; Pfizer's CEO pushes back against Donald Trump's depiction of the pharmaceutical industry; some Republican governors urge caution on Obamacare repeal.
With Donald J. Trump’s administration poised to enter the White House, California has backed off a request to sell unsubsidized health insurance to illegal immigrants. According to AP, Covered California was notified that the request in to CMS would face a 1-month comment period and a 180-day window for the final decision, which would let the decision fall to Trump’s administration. Currently, immigrants who do not have legal status can buy health coverage through an insurance agent.
One pharmaceutical executive is pushing back against Trump’s depiction of the industry. At the World Economic Forum in Davos, Switzerland, Pfizer’s CEO said pharmaceutical companies are not, as Trump said, “getting away with murder,” according to FiercePharma. Ian Read said the reputation that the pharmaceutical industry has gotten does not represent the ethical part of the industry. He distanced himself from Martin Shkreli, the former CEO of Turing Pharma, as well as Valeant Pharmaceuticals.
Some Republican governors are urging that Republican lawmakers show caution as they work to repeal the Affordable Care Act. Governors who have expanded Medicaid are concerned about the effect of repealing the healthcare law, reported The Wall Street Journal. Ohio Governor John Kasich will join at least 8 other governors and 2 lieutenant governors for a roundtable, Senate Finance Committee Republicans, on the future of Medicaid expansion.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More